Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 19 | 2024 | 911 | 3.260 |
Why?
|
| Peritoneal Dialysis | 9 | 2024 | 131 | 2.450 |
Why?
|
| Renal Dialysis | 14 | 2024 | 875 | 1.530 |
Why?
|
| Catheters, Indwelling | 4 | 2024 | 142 | 1.260 |
Why?
|
| Catheter-Related Infections | 6 | 2024 | 104 | 1.070 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 775 | 0.980 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 2 | 2020 | 21 | 0.820 |
Why?
|
| Hydrothorax | 1 | 2020 | 11 | 0.680 |
Why?
|
| Calcimimetic Agents | 1 | 2019 | 5 | 0.660 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 17 | 0.650 |
Why?
|
| Kidney Transplantation | 4 | 2023 | 681 | 0.490 |
Why?
|
| Renal Insufficiency | 4 | 2024 | 249 | 0.470 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2019 | 53 | 0.450 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2014 | 84 | 0.430 |
Why?
|
| Latent Tuberculosis | 1 | 2014 | 76 | 0.420 |
Why?
|
| Child | 26 | 2024 | 25711 | 0.410 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2022 | 94 | 0.350 |
Why?
|
| Catheterization | 3 | 2022 | 236 | 0.320 |
Why?
|
| Renal Replacement Therapy | 3 | 2023 | 151 | 0.320 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2023 | 82 | 0.320 |
Why?
|
| Nephrosis, Lipoid | 1 | 2009 | 11 | 0.310 |
Why?
|
| Nephrotic Syndrome | 1 | 2009 | 52 | 0.300 |
Why?
|
| Cost Savings | 1 | 2008 | 76 | 0.300 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 225 | 0.290 |
Why?
|
| Infant | 11 | 2024 | 13123 | 0.270 |
Why?
|
| Oxygen | 2 | 2021 | 577 | 0.270 |
Why?
|
| Ascitic Fluid | 2 | 2017 | 31 | 0.270 |
Why?
|
| Child, Preschool | 12 | 2024 | 14762 | 0.260 |
Why?
|
| Humans | 35 | 2024 | 133589 | 0.250 |
Why?
|
| Adolescent | 17 | 2024 | 20512 | 0.250 |
Why?
|
| Hypertension | 2 | 2019 | 1388 | 0.250 |
Why?
|
| Health Care Costs | 1 | 2008 | 403 | 0.240 |
Why?
|
| Peritonitis | 2 | 2024 | 79 | 0.230 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 676 | 0.230 |
Why?
|
| Retrospective Studies | 12 | 2023 | 17437 | 0.230 |
Why?
|
| Nephrology | 2 | 2016 | 152 | 0.220 |
Why?
|
| Observer Variation | 1 | 2024 | 313 | 0.210 |
Why?
|
| Pruritus | 1 | 2023 | 43 | 0.210 |
Why?
|
| Oximetry | 2 | 2021 | 174 | 0.200 |
Why?
|
| Male | 21 | 2024 | 65783 | 0.200 |
Why?
|
| Kidney | 3 | 2023 | 1405 | 0.200 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2022 | 33 | 0.190 |
Why?
|
| Ureteral Obstruction | 1 | 2023 | 109 | 0.190 |
Why?
|
| Arteriovenous Fistula | 1 | 2022 | 55 | 0.180 |
Why?
|
| Ureter | 1 | 2023 | 100 | 0.180 |
Why?
|
| Brain Chemistry | 1 | 2021 | 125 | 0.180 |
Why?
|
| Standard of Care | 2 | 2019 | 136 | 0.170 |
Why?
|
| Hematocrit | 1 | 2020 | 116 | 0.170 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 271 | 0.170 |
Why?
|
| Blood | 1 | 2020 | 105 | 0.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 57 | 0.170 |
Why?
|
| Veins | 1 | 2020 | 108 | 0.160 |
Why?
|
| Female | 16 | 2024 | 71528 | 0.160 |
Why?
|
| Infant Formula | 1 | 2020 | 100 | 0.160 |
Why?
|
| Venous Thrombosis | 2 | 2019 | 169 | 0.160 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 243 | 0.150 |
Why?
|
| Guideline Adherence | 2 | 2019 | 393 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2019 | 104 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 114 | 0.150 |
Why?
|
| Creatinine | 1 | 2020 | 423 | 0.150 |
Why?
|
| Pediatrics | 3 | 2019 | 1209 | 0.150 |
Why?
|
| Bacteremia | 1 | 2022 | 417 | 0.150 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8572 | 0.150 |
Why?
|
| Arterial Pressure | 1 | 2019 | 121 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 136 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 138 | 0.140 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 72 | 0.140 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 80 | 0.140 |
Why?
|
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 9 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 391 | 0.140 |
Why?
|
| Sevelamer | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hyperphosphatemia | 1 | 2017 | 18 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 549 | 0.140 |
Why?
|
| Chelating Agents | 1 | 2017 | 45 | 0.140 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 18 | 0.140 |
Why?
|
| Lung Transplantation | 1 | 2021 | 334 | 0.140 |
Why?
|
| Chylous Ascites | 1 | 2017 | 11 | 0.140 |
Why?
|
| Milk, Human | 1 | 2020 | 311 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 536 | 0.130 |
Why?
|
| Heart | 1 | 2021 | 756 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2023 | 13003 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 144 | 0.130 |
Why?
|
| Peritoneum | 1 | 2016 | 40 | 0.120 |
Why?
|
| Texas | 3 | 2017 | 3678 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 234 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 128 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2019 | 687 | 0.120 |
Why?
|
| Quality of Life | 2 | 2023 | 2127 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 11054 | 0.120 |
Why?
|
| Sepsis | 1 | 2019 | 525 | 0.120 |
Why?
|
| Public Policy | 1 | 2015 | 54 | 0.110 |
Why?
|
| Skin Tests | 1 | 2014 | 84 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 160 | 0.110 |
Why?
|
| Young Adult | 5 | 2019 | 9897 | 0.100 |
Why?
|
| Hyperammonemia | 1 | 2013 | 63 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1021 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 713 | 0.090 |
Why?
|
| Transplant Recipients | 2 | 2022 | 225 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 504 | 0.080 |
Why?
|
| Incidence | 1 | 2018 | 3386 | 0.080 |
Why?
|
| Glomerular Mesangium | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2009 | 5180 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 769 | 0.080 |
Why?
|
| Cyclosporine | 1 | 2009 | 148 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5491 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 433 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2008 | 114 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 335 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 454 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 402 | 0.070 |
Why?
|
| Age Factors | 3 | 2021 | 2977 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2009 | 225 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 31933 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 417 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 565 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 3067 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3473 | 0.060 |
Why?
|
| Biopsy | 1 | 2009 | 1302 | 0.060 |
Why?
|
| United States | 2 | 2018 | 11654 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 690 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 791 | 0.050 |
Why?
|
| Nitrogen | 1 | 2024 | 148 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 241 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3739 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 35 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2024 | 328 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 105 | 0.050 |
Why?
|
| Living Donors | 1 | 2022 | 118 | 0.050 |
Why?
|
| Blood Volume | 1 | 2021 | 83 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2024 | 6650 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 87 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2019 | 21 | 0.040 |
Why?
|
| Graft Survival | 1 | 2022 | 557 | 0.040 |
Why?
|
| Renal Veins | 1 | 2019 | 34 | 0.040 |
Why?
|
| Iliac Vein | 1 | 2019 | 30 | 0.040 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 43 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2019 | 64 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2019 | 48 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 51 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2021 | 541 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 168 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 196 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 348 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 477 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2022 | 624 | 0.040 |
Why?
|
| Imidazoles | 1 | 2019 | 218 | 0.040 |
Why?
|
| Arteries | 1 | 2019 | 222 | 0.040 |
Why?
|
| Iohexol | 1 | 2017 | 23 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2019 | 455 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2017 | 32 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2021 | 872 | 0.030 |
Why?
|
| Nephrology Nursing | 1 | 2016 | 2 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Decision Trees | 1 | 2016 | 52 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 78 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 485 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 265 | 0.030 |
Why?
|
| Myocardium | 1 | 2021 | 1058 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1118 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 820 | 0.030 |
Why?
|
| Aorta | 1 | 2019 | 557 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 621 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2307 | 0.030 |
Why?
|
| Foundations | 1 | 2015 | 22 | 0.030 |
Why?
|
| Government | 1 | 2015 | 15 | 0.030 |
Why?
|
| Thrombosis | 1 | 2019 | 536 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 613 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 382 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1047 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 590 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 517 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 766 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1694 | 0.020 |
Why?
|
| Reoperation | 1 | 2016 | 866 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1333 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2016 | 571 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 867 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1967 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 651 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3411 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2016 | 513 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1334 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2935 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3208 | 0.010 |
Why?
|